Study of VC005 tablets for active ankylosing spondylitis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy clinical trials.
This trial tests a new tablet called VC005 to see if it helps reduce pain and stiffness in people with active ankylosing spondylitis. It's a phase 3 study, meaning it's one of the final steps before the drug may be approved for wider use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have been diagnosed with ankylosing spondylitis (a type of arthritis affecting the spine).
- You cannot be allergic to VC005 or similar drugs.
- You cannot have had an organ transplant that requires ongoing immunosuppressants.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
This trial tests a Chinese herbal tablet called Jitongning against a placebo to see if it can improve overall symptoms in people with active axial osteoarthritis. You may be eligible if your arthritis is active, you have a specific genetic marker (HLA-B27 positive), and your inflammation levels are high.
This study tests a new medication (called 608) to see if it helps reduce pain and inflammation in people with a type of spinal arthritis that isn't visible on X-rays. If you have persistent back pain and signs of inflammation, this treatment might offer a new option to feel better.
This trial tests an oral tablet called VC005 to see if it can help treat non-segmental vitiligo. It may be an option for adults with vitiligo patches that are not limited to one area of the body.
This trial tests a pain-relieving drug called acemetacin for people with axial spondyloarthritis (a type of arthritis affecting the spine and pelvis). The drug aims to reduce pain and inflammation, and this study will see how well it works in real life.
Hear when a new Active Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.